Drug Discovery Solutions
-
SUREmAb — Monoclonal Antibody Development, The Way It's Meant To Be
8/4/2023
Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.
-
Drug Substance Synthesis And Manufacturing
3/3/2022
We take an agile and flexible approach with our customers programs, offering bespoke drug substance synthesis and manufacturing, helping to accelerate molecules from candidate selection to clinical proof-of-concept and onwards towards commercial scale.
-
Expediting Drug Discovery From Concept To Commercialization
8/13/2024
Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.
-
Leveraging Proprietary CDO Platforms
Explore how a suite of proprietary CDO platforms for BsAbs, transient expression, developability assessment, and more can help optimize every stage of development and accelerate your project timeline.
-
Use The Right Tools To Improve Cell Lines And Production Yields
5/15/2023
Learn about antibody production and purification, engineering antibodies for developability, and antibody humanization while also exploring an integrated pipeline that enables the direct application of machine learning tools.
-
Delivering Global ADC Development Solutions
10/7/2025
Gain access to industry-leading scientific capabilities, integrated platforms, and specialized expertise that help streamline antibody-drug conjugate discovery and development.
-
TARGATTâ„¢ iPSC Kits
9/30/2025
Build cell-based models of disease and accelerate therapeutic development with TARGATT™ large knock-in technology in iPSCs.
-
PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production
3/17/2023
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
-
DNA2.0 - Gene Optimization And Synthesis
2/13/2024
ATUM is building on DNA2.0's reputation for rapid, reliable and accurate DNA synthesis. Using our proprietary GeneGPS® and VectorGPS® platforms we design constructs optimized to express in your system, whether that's a single gene in E. coli, a metabolic pathway in yeast or a complex bispecific antibody in mammalian cells.
-
Protein Degraders: From Discovery To Development
11/18/2025
Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.